Document is current
Any future updates will be listed below
-
Authors
Martinovic, Vanja
Nikolic, Ivan
Mesaros, Sarlota
Drulovic, Jelena
-
Funding
Funding for this research was provided by:
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (175031, 175087)
- License Information
-
More Information
Article History
Received: 18 August 2018
Accepted: 8 December 2018
First Online: 17 December 2018
Compliance with ethical standards
:
: Jelena Drulovic: serves on scientific advisory boards for Bayer Schering Pharma, Merck Serono, TEVA, Sanofi Genzyme and received honoraria for speaking from Merck Serono, Teva, Bayer Schering, Sanofi Genzyme, Medis. She is the principal investigator in clinical trials for Merck Serono, Teva, Biogen Idec, Roche, Genzyme, a Sanofi Company, Receptos. Sarlota Mesaros: speaker’s honoraria for Merck Serono and Novartis, travel grants from Bayer and Genzyme a Sanofi. Vanja Martinović declares that she has no conflict of interest. Ivan Nikolic declares that he has no conflict of interest.
: All procedures performed in this study were in accordance with ethical standards and approved by the Institutional Review Board.
: Informed consent was obtained from a patient included in the case-report.
